ES2054667T3 - Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso. - Google Patents

Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso.

Info

Publication number
ES2054667T3
ES2054667T3 ES87303762T ES87303762T ES2054667T3 ES 2054667 T3 ES2054667 T3 ES 2054667T3 ES 87303762 T ES87303762 T ES 87303762T ES 87303762 T ES87303762 T ES 87303762T ES 2054667 T3 ES2054667 T3 ES 2054667T3
Authority
ES
Spain
Prior art keywords
arg74
des
monoclonal antibodies
production
antibodies against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87303762T
Other languages
English (en)
Inventor
James W Larrick
Brian M Fendly
Tracey E Deinhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cetus Oncology Corp
Original Assignee
Cetus Oncology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Oncology Corp filed Critical Cetus Oncology Corp
Application granted granted Critical
Publication of ES2054667T3 publication Critical patent/ES2054667T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE PRODUCEN ANTICUERPOS MONOCLONALES QUE SE CARACTERIZA POR SU APTITUD PARA COMBINARSE CON EL COMPONENTE DEL COMPLEMENTO HUMANO C5A. ESTOS ANTICUERPOS SON PARTICULARMENTE UTILES PARA EL TRATAMIENTO DE ESTADOS ASOCIADOS CON LA ACTIVACION DEL COMPLEMENTO INTRAVASCULAR NOCIVA O CAUSADOS POR ELLA. ADEMAS, ESTOS ANTICUERPOS PUEDEN UTILIZARSE EN UN METODO INMUNOLOGICO O DE INMUNODIAGNOSTICO PARA DETECTAR C5A O DES-ARG74-C5A EN HUMANOS EN FLUIDOS.
ES87303762T 1986-04-28 1987-04-28 Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso. Expired - Lifetime ES2054667T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85678086A 1986-04-28 1986-04-28
US94783986A 1986-12-30 1986-12-30

Publications (1)

Publication Number Publication Date
ES2054667T3 true ES2054667T3 (es) 1994-08-16

Family

ID=27127377

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87303762T Expired - Lifetime ES2054667T3 (es) 1986-04-28 1987-04-28 Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso.

Country Status (4)

Country Link
EP (1) EP0245993B1 (es)
JP (2) JP2703764B2 (es)
DE (1) DE3785967T2 (es)
ES (1) ES2054667T3 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO162210C (no) * 1987-07-20 1989-11-22 Fasting Biotech As Monoklonale antistoffer mot c5a for in-vitro anvendelse ved immunologiske kvantitative teknikker eller ved isolering av c5a.
DE3924924A1 (de) * 1989-07-27 1991-02-07 Goetze Otto Verfahren zum nachweis und/oder der quantitativen bestimmung von komplementpeptid c5a und/oder c5adesarg
CA2176825A1 (en) * 1993-12-06 1995-06-15 Jan Van Oostrum C5a receptor antagonists having substantially no agonist activity
US5837499A (en) * 1993-12-06 1998-11-17 Ciba-Geigy Corporation DNA encoding C5A receptor antagonists having substantially no agonist activity and methods of expressing same
US5807824A (en) * 1993-12-06 1998-09-15 Ciba-Geigy Corporation C5A receptor antagonists having substantially no agonist activity
WO1996009043A1 (en) 1994-09-23 1996-03-28 Alexion Pharmaceuticals, Inc. Methods for the treatment of inflammatory joint disease
US6673346B1 (en) 1999-08-31 2004-01-06 The Regents Of The University Of Michigan Compositions and methods for the treatment of sepsis
ES2283594T5 (es) * 2001-08-17 2016-03-15 Genentech, Inc. Inhibidores de la ruta del complemento que se unen a C5 y C5a sin impedir la formación de C5b
US7455837B2 (en) * 2002-11-05 2008-11-25 The Regents Of The University Of Michigan Compositions and methods for the diagnosis and treatment of sepsis
EP1628530B8 (en) * 2003-05-15 2012-08-01 Genentech, Inc. Methods and compositions for the prevention and treatment of sepsis
US9011852B2 (en) * 2010-04-30 2015-04-21 Alexion Pharmaceuticals, Inc. Anti-C5a antibodies
CN103154633B (zh) * 2010-08-06 2017-06-06 伊诺乐恩股份有限公司 用于太阳能热电站的高温热量存储器
EP2468295A1 (en) 2010-12-21 2012-06-27 Affiris AG Vaccines based on peptides of the complement protein C5a
EP2666785A1 (en) 2012-05-23 2013-11-27 Affiris AG Complement component C5a-based vaccine
CR20160132A (es) 2013-08-12 2016-08-25 Genentech Inc Composiciones y método para tratar condiciones asociadas con el complemento
NZ631007A (en) * 2014-03-07 2015-10-30 Alexion Pharma Inc Anti-c5 antibodies having improved pharmacokinetics
MX2016014160A (es) 2014-05-01 2017-02-16 Genentech Inc Variantes del anticuerpo anti-factor d y sus usos.
WO2017075252A1 (en) 2015-10-30 2017-05-04 Genentech, Inc. Anti-factor d antibody variant conjugates and uses thereof
JP2018534930A (ja) 2015-10-30 2018-11-29 ジェネンテック， インコーポレイテッド 抗ｄ因子抗体及びコンジュゲート
WO2017142055A1 (ja) * 2016-02-17 2017-08-24 国立大学法人 東京医科歯科大学 動脈硬化性疾患の発症の予測因子および検査方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0286099A3 (en) * 1983-05-06 1988-12-21 Velos Group Monoclonal antibodies reactive with endotoxin core

Also Published As

Publication number Publication date
EP0245993A3 (en) 1989-07-26
DE3785967T2 (de) 1993-12-02
DE3785967D1 (de) 1993-07-01
JP2820402B2 (ja) 1998-11-05
JPH10130167A (ja) 1998-05-19
EP0245993B1 (en) 1993-05-26
JP2703764B2 (ja) 1998-01-26
JPS62269699A (ja) 1987-11-24
EP0245993A2 (en) 1987-11-19

Similar Documents

Publication Publication Date Title
ES2054667T3 (es) Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso.
ATE161582T1 (de) Monoklonale antikörper der maus
FR1274917A (fr) Procédé de captation et de ramassage de résidus pétroliers ou autres sur les eaux portuaires, et éléments pour son application
NL7602704A (nl) Werkwijze en inrichting voor de behandeling van waterhoudende stoffen, alsmede toepassing van de werkwijze op de vervaardiging van gepasteuriseerd droogslib.
DE68900371D1 (de) Textile struktur zur herstellung von schichtstoffen und schichtformteile, die diese struktur enthalten.
NO873699D0 (no) Polypeptid som er egnet til dempning, behandling og diagnosering av autoimmune lidelser saasom leddbetennelser.
NO873495L (no) Monoklonale antistoffer og peptider som kan anvendes til behandling og diagnose av hiv-infeksjoner.
BR112022011570A2 (pt) Anticorpos anti-mertk e métodos de uso dos mesmos
AT265991B (de) Verfahren und Vorrichtung zur Herstellung von Gemischen, Lösungen, Emulsionen, Suspensionen u.dgl. sowie zur biologischen Reinigung von freien Gewässern
ES2062809T3 (es) Proteinas bacterianas del estres.
FR2491334B1 (es)
DE69816796D1 (de) Pharmazeutische oder nahrungsmittelzusammensetzung für die behandlung von pathologien die assoziiert sind mit einem transplantatabstoss, einer allergischen oder autoimmunreaktion
DK322583D0 (da) Middel til behandling af sar
SE7608174L (sv) Forfarande for framstellning av antiserum
ES2058343T3 (es) Piridinas disubstituidas.
ES2059418T3 (es) Antigeno asociado a carcinoma humano y anticuerpo asociado al antigeno.
ATE71149T1 (de) Monoklonale antikoerper.
ATE45562T1 (de) Glasgefaess, insbesondere ampulle, und verfahren zur behandlung dieses glasgefaesses.
ES510542A0 (es) "procedimiento para la absorcion isotermica del oxido de etileno contenido en el gas procedente de una instalacion para la produccion de oxido de etileno".
BR8907500A (pt) Hidrofluoretacao catalisada de alcenos
CH554892A (de) Verfahren zur herstellung von 1,5-substituierten oder 1,6substituierten benzimidazolen.
KR910016342A (ko) 항원 용액을 위한 보조제로서의 아연, 칼슘 하이드록 사이드, 렉시틴 및 pao의 용도, 및 이러한 유형의 보조제로 처리된 항원 용액
NL138767B (nl) Werkwijze ter verbetering van de filtratie-eigenschappen van asbestvezels, alsmede aldus verkregen vezels en onder toepassing daarvan verkregen filtratie-elementen.
NO173831C (no) Nye monoklonale antistoffer mot IFN-omega, hybridomer til fremstilling derav og anvendelse for rensing samt paavisning eller kvantitativ bestemmelse av IFN-omega, og sett for bruk ved paavisningen
ES2038597T3 (es) Metodo para detectar anticuerpos neutralizantes de virus en una muestra acuosa.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 245993

Country of ref document: ES